PTAB Nixes Genzyme Muscle Disease Treatment Patents
The Patent Trial and Appeal Board found Monday that BioMarin Pharmaceutical Inc. had proven that Genzyme Therapeutic Products Ltd. Partnership's patents on methods of treating a muscle disease are invalid, in...To view the full article, register now.
Already a subscriber? Click here to view full article